MK-801, a non-competitive antagonist of NMDA receptor, prevents methamphetamine-induced decrease of striatal dopamine uptake sites in the rat striatum
Authors:
- Tsukasa KoyamaTKTsukasa Koyama
- Makoto NakayamaMNMakoto Nakayama
- Tetsuro OhmoriTOTetsuro Ohmori
- Itaru YamashitaIYItaru Yamashita
- 17 February 1992
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 136 (1) , 39-42
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- MK-801 attenuates the dopamine-releasing but not the behavioral effects of methamphetamine: an in vivo microdialysis studyBrain Research, 1991
- Role for Excitatory Amino Acids in Methamphetamine-Induced Nigrostriatal Dopaminergic ToxicityScience, 1989
- Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801Life Sciences, 1989
- Modulatory Effect of Dopamine on High‐Affinity Glutamate Uptake in the Rat StriatumJournal of Neurochemistry, 1987
- Characterization of Sodium‐Dependent [3H]GBR‐12935 Binding in Brain: A Radioligand for Selective Labelling of the Dopamine Transport ComplexJournal of Neurochemistry, 1986
- Hypoglycemia-Induced Neuronal Damage Prevented by an N -Methyl-D-Aspartate AntagonistScience, 1985
- Blockade of N -Methyl-D-Aspartate Receptors May Protect Against Ischemic Damage in the BrainScience, 1984
- Anticonvulsant Action of Excitatory Amino Acid AntagonistsScience, 1982
- Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamineBrain Research, 1980
- Long-term administration of d-amphetamine: Progressive augmentation of motor activity and stereotypyPharmacology Biochemistry and Behavior, 1974